VAXBRIEF

Category: Uncategorized

  • Daily Brief 10th Feb 2026

    —

    by

    VaxBrief Editorial
    in

    The current narrative environment shows sustained circulation of two evergreen vaccine narratives—DNA contamination/genomic integration claims and excess mortality attribution—alongside region-specific signals in New Zealand and Australia related to procurement and regulatory funding. A newly rising New Zealand sentinel narrative frames limited access to non-mRNA vaccines as coercive policy rather than procurement outcome. Regulatory divergence between…

  • Daily Brief 1st Feb 2026

    —

    by

    VaxBrief Editorial
    in

    Current vaccine-related narratives continue to focus on mRNA platforms, with persistent claims about DNA contamination, genomic integration, bio-persistence, and excess mortality. These narratives draw on regulatory updates, pharmacokinetic findings, and national mortality statistics, which are being framed as evidence of long-term harm. In Australia and New Zealand, procurement and access decisions are being interpreted as…

  • Daily Brief – Jan 21st 2026

    —

    by

    VaxBrief Editorial
    in , ,

    Data Window: January 21, 2026 (rolling 24-hour scan)Regions: United States · Canada · United Kingdom · Australia · New Zealand Summary Narratives in the past 24 hours centre on Scientific Decoupling following a U.S. HHS shift moving six childhood vaccines from Routine to Shared Clinical Decision-Making. Discussion focuses on perceived divergence from peer-country schedules and uncertainty about…